跳至主要内容
临床试验/CTRI/2020/11/029120
CTRI/2020/11/029120暂停未知

To assess the outcome of Acanthamoeba keratitis on combination of topical Biguanides and oral Miltefosine.

V Prasad Eye Instituta0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
暂停
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1.Patients with age more than 18 years
  • 2.Microbiologically proven Acanthamoeba keratitis
  • 3.Patients willing to participate and follow up.

排除标准

  • 1.Patients with age less than 18 years
  • 2.Pregnant and lactating females
  • 3.Patients who are likely to be pregnant are relative contraindicated.
  • 4.Patient not willing to participate and follow up
  • 5.Patients with known allergy to Miltefosine
  • 6.Patients with epithelial or sub epithelial keratitis with only anterior stroma involvement with less than 4 mm.

研究者

发起方
V Prasad Eye Instituta

相似试验